Medicine & Life Sciences
Acute Liver Failure
17%
Allografts
60%
Anti-Idiotypic Antibodies
5%
Antibodies
24%
Artificial Liver
38%
Biopsy
23%
Blood Group Antigens
5%
Cell- and Tissue-Based Therapy
8%
Cholangiocarcinoma
14%
Clinical Trials
6%
Cyclosporine
7%
Dendritic Cells
6%
Dialysis
5%
eculizumab
7%
End Stage Liver Disease
14%
Fibrosis
15%
fumarylacetoacetase
8%
Glomerular Filtration Rate
12%
Graft Survival
20%
Heart Transplantation
5%
Hepacivirus
5%
Hepatocellular Carcinoma
14%
Hepatocytes
31%
Histology
7%
HLA Antigens
5%
Hypertension
6%
Immunosuppression
12%
Immunosuppressive Agents
6%
Incidence
8%
Inflammation
6%
Isoantibodies
18%
Kidney
73%
Kidney Transplantation
62%
Klatskin Tumor
25%
Liver
34%
Liver Diseases
13%
Liver Failure
5%
Liver Regeneration
5%
Liver Transplantation
100%
Living Donors
49%
Mesenchymal Stem Cells
7%
Mortality
9%
Mycophenolic Acid
6%
Neoadjuvant Therapy
5%
Neoplasms
5%
Nephrectomy
5%
Obesity
6%
Organ Transplantation
9%
Pancreas
13%
Pancreas Transplantation
22%
Plasma Cells
6%
Proteinuria
5%
Psychology Rejection
6%
Recurrence
7%
Renal Insufficiency
6%
Sclerosing Cholangitis
10%
Serum
6%
Sirolimus
8%
Survival
16%
Swine
18%
Tacrolimus
15%
Therapeutics
11%
Tissue Donors
50%
Transplant Recipients
32%
Transplantation
35%
Transplants
82%
Tyrosinemias
7%
Wounds and Injuries
7%